Skip to main content
PMC home page
Antimicrobial Agents and Chemotherapy logoLink to Antimicrobial Agents and Chemotherapy
. 1979 May;15(5):670–673. doi: 10.1128/aac.15.5.670

Pharmacokinetics of Bay k 4999, a New Broad-Spectrum Penicillin

R Wise 1, B Cadge 1, A P Gillett 1, A Bhamjee 1, R Livingston 1, P G Welling 2, D P Thornhill †
PMCID: PMC352736  PMID: 525984

Abstract

The pharmacokinetics of the broad-spectrum penicillin Bay k 4999 were studied in six healthy male volunteers. A 2-g dose was given by the intravenous route. The tissue penetration of the antibiotic was studied by both dermabrasion and blister techniques. A total of 26.4% of the drug was recovered in the urine in 24 h, 79% of this being excreted in the first 2 h. The elimination half-life in serum was 1.3 h. The dermabrasion levels of Bay k 4999 were generally similar to those in serum, but after 1 h the blister fluid levels of antibiotic were greater than those in serum. Different drug levels obtained by blister and dermabrasion techniques may be due to the different composition of the two fluids.

Full text

PDF
670

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Boxenbaum H. G., Riegelman S., Elashoff R. M. Statistical estimations in pharmacokinetics. J Pharmacokinet Biopharm. 1974 Apr;2(2):123–148. doi: 10.1007/BF01061504. [DOI] [PubMed] [Google Scholar]
  2. Evans M. A., Wilson P., Leung T., Williams J. D. Pharmacokinetics of piperacillin following intravenous administration. J Antimicrob Chemother. 1978 May;4(3):255–261. doi: 10.1093/jac/4.3.255. [DOI] [PubMed] [Google Scholar]
  3. Gillett A. P., Wise Penetration of four cephalosporins into tissue fluid in man. Lancet. 1978 May 6;1(8071):962–964. doi: 10.1016/s0140-6736(78)90250-7. [DOI] [PubMed] [Google Scholar]
  4. Knudsen E. T., Rolinson G. N., Sutherland R. Carbenicillin: a new semisynthetic penicillin active against Pseudomonas pyocyanea. Br Med J. 1967 Jul 8;3(5557):75–78. doi: 10.1136/bmj.3.5557.75. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. König H. B., Metzger K. G., Mürmann R. P., Offe H. A., Schacht P., Schröck W. Azlocillin-ein neues Penicillin gegen Pseudomonas aeruginosa und andere gramnegative Bakterien. Infection. 1977;5(3):170–182. doi: 10.1007/BF01639754. [DOI] [PubMed] [Google Scholar]
  6. Lode H., Niestrath U., Koeppe P., Langmaack H. Azlocillin und Mezlocillin: Zwei neue semisynthetische Acylureidopenicilline. Infection. 1977;5(3):163–169. doi: 10.1007/BF01639753. [DOI] [PubMed] [Google Scholar]
  7. Raeburn J. A. A method for studying antibiotic concentrations in inflammatory exudate. J Clin Pathol. 1971 Oct;24(7):633–635. doi: 10.1136/jcp.24.7.633. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Simon C., Malerczyk V., Brahmstaedt E., Toeller W. Cefazolin, ein neues Breitspektrum-Antibiotikum. Dtsch Med Wochenschr. 1973 Dec 21;98(51):2448–2450. doi: 10.1055/s-0028-1107275. [DOI] [PubMed] [Google Scholar]
  9. Stewart D., Bodey G. P. Azlocillin: in vitro studies of a new semisynthetic penicillin. Antimicrob Agents Chemother. 1977 May;11(5):865–870. doi: 10.1128/aac.11.5.865. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Verbist L. In vitro activity of piperacillin, a new semisynthetic penicillin with an unusually broad spectrum of activity. Antimicrob Agents Chemother. 1978 Mar;13(3):349–357. doi: 10.1128/aac.13.3.349. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Wise R., Andrews J. M., Bedford K. A. Comparison of the in vitro activity of Bay k 4999 and piperacillin, two new antipseudomonal broad-spectrum penicillins, with other beta-lactam drugs. Antimicrob Agents Chemother. 1978 Oct;14(4):549–552. doi: 10.1128/aac.14.4.549. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Wise R., Gillett A. P., Andrews J. M., Bedford K. A. Activity of azlocillin and mezlocillin against gram-negative organisms: comparison with other penicillins. Antimicrob Agents Chemother. 1978 Apr;13(4):559–565. doi: 10.1128/aac.13.4.559. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Antimicrobial Agents and Chemotherapy are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES